Pharmacyclics (PCYC)
Pharmacyclics Receivables Turnover: 28.60
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
PCYC Receivables Turnover Rankings
| Overall | 90th percentile | 332 of 3460 |
| Sector | 93rd percentile | 27 of 392 in Healthcare |
| Industry | 89th percentile | 3 of 28 in Drug Manufacturers - Other |
PCYC Receivables Turnover Range, Past 5 Years
| Minimum | 28.60 | Mar 2012 |
| Maximum | 302.55 | Dec 2011 |
| Average | 102.28 |
About Receivables Turnover Ratio
The receivable turnover ratio quantifies a company's ability to collect liabilities/debts. It helps investors gauge the efficiency of a company's collection and credit policies.
A high ratio value indicates an efficient and effective credit policy, and a low ratio indicates a debt collection problem.
The way to read the receivables turnover ratio is as follows. Assume that a company has a receivables turnover ratio of 10. We say that "the company turns over its receivables 10 times during the year." In other words, on average the company collects its outstanding receivables 10 times per year.
Learn More
You may also be interested in these PCYC related companies
PCYC News
$PCYC http://stks.co/43iw Consolidating very well.. keep an eye on it..
about 3 hours ago by vjtweet
about 3 hours ago by vjtweet
Worksheet for @stocktwits50 http://stks.co/40or $ARBA $LQDT $HAIN $EXPE $ALLT $ALGT $Z $ACHC $SXCI $PCYC
about 3 days ago by tradewithpete
about 3 days ago by tradewithpete
Headstart on whats working RT @StockTwits Best StockTwits50 Performers for the week: $ARBA $DDD $PCYC $EXPE $UA $Z http://stks.co/40RM
about 3 days ago by howardlindzon
about 3 days ago by howardlindzon
$vvus, $mdvn, $pcyc have done well, but they will explode once the market starts getting some traction again.
about 3 days ago by lennylex
about 3 days ago by lennylex
Best StockTwits50 Performers for the week: $ARBA $DDD $PCYC $EXPE $UA $Z http://stks.co/3zan
about 7 days ago by StockTwits
about 7 days ago by StockTwits
$PCYC http://stks.co/3y50 Looks to be getting a little overbought here. Lets see if it can keep running to end the week off.
about 8 days ago by ACInvestorBlog
about 8 days ago by ACInvestorBlog
$PCYC short-term target 35, intermediate-term 39. $VVUS if takes out wedge, look for test of highs around 26 1/4-1/2. http://stks.co/3wGp
about 10 days ago by thetechtrader
about 10 days ago by thetechtrader
El Gato Muerto | via @downtowntrader http://stks.co/3vn2 $SPY $FIRE $PCYC
about 10 days ago by STNet
about 10 days ago by STNet
$PCYC http://stks.co/3vlu This biotech is acting strong. A solid move into highs yesteday.
about 10 days ago by DanZanger
about 10 days ago by DanZanger
El Gato Muerto http://stks.co/3vlY via @DowntownTrader $PCYC $FIRE $SPY
about 10 days ago by StockTwits
about 10 days ago by StockTwits
$PCYC http://stks.co/3vaZ Broke out to new highs on solid volume. I think we will see some nice follow through tomorrow
about 10 days ago by ACInvestorBlog
about 10 days ago by ACInvestorBlog
$BWS http://stks.co/3vU7 $BWS $PVA $PCYC $FRO Full blog post here http://stks.co/3vU8
about 10 days ago by LincolnList
about 10 days ago by LincolnList
Notable 52-Week Highs and Lows of the Day 05/17: (ARRY) (NTES) (PCYC) High; (WFR) (VALE) (CLWR) Low
May 17, 3:42PM Street Insider
May 17, 3:42PM Street Insider
2012 Economic Outlook - Report Highlights Acorda Therapeutics Inc and Pharmacyclics, Inc.
May 17, 9:00AM Marketwire
May 17, 9:00AM Marketwire
Pharmacyclics, Inc. (PCYC) Posts Narrower than Expected Q1 Loss of 14c/Share
May 10, 6:40AM Street Insider
May 10, 6:40AM Street Insider
Pharmacyclics Reports Fiscal 2012 Third Quarter Financial Results and Recent Developments
May 10, 6:00AM PR Newswire
May 10, 6:00AM PR Newswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PCYC | 31.42 | -0.68 | -2.12% | 2.209B |
| PCY | 27.70 | +0.03 | +0.09% | |
| PCX | 2.37 | -0.01 | -0.42% | 221.15M |
| PCTI | 6.11 | +0.09 | +1.50% | 111.31M |
| PCS | 6.40 | +0.07 | +1.11% | 2.295B |
| PCRX | 10.62 | -0.05 | -0.47% | 271.12M |
| PCP | 166.21 | -0.41 | -0.25% | 24.19B |
| PCOM | 11.27 | +0.05 | +0.45% | 169.09M |
| PCN | 16.19 | +0.09 | +0.56% | |
| PCM | 10.94 | -0.03 | -0.27% |
